Equine Tetanus at a Glance
Tetanus Case Outcomes
Comparison
| Scenario | Risk Level | Action | Cost |
|---|---|---|---|
| Up-to-Date Vax | Very low | No action needed | $25–50 annual |
| Overdue Booster | Moderate | Booster within 24h of wound | $25–50 |
| Unvaccinated + Wound | HIGH | Antitoxin + tetanus toxoid | $100–250 |
| Clinical Tetanus | Critical | ICU hospitalization, 2–4 weeks | $5,000+ |
Tetanus Prevention Protocol
Tetanus Prevention Checklist
| Vaccinate all horses annually | |
| Give booster within 24 hours of any wound | |
| Use tetanus toxoid for at-risk unvaccinated horses | |
| Administer tetanus antitoxin only if no history of vaccination | |
| Keep accurate vaccination records | |
| Vaccinate broodmares 4–6 weeks before foaling | |
| Foals: start vaccination series at 4–6 months | |
| Any puncture wound in unvaccinated horse = emergency |
Tetanus is caused by Clostridium tetani toxin and kills approximately 80% of horses that develop clinical signs, even with intensive treatment. C. tetani spores are ubiquitous in soil, particularly in well-manured pastures and stable environments -- exactly where horses live. Any wound, no matter how small, can introduce the organism. The tetanus toxoid vaccine is safe, inexpensive, and highly effective: vaccinated horses almost never develop tetanus. Unvaccinated horses that sustain a wound are in serious danger. This vaccine is non-negotiable in equine medicine.
| Vaccination Stage | Timing | Notes |
|---|---|---|
| Primary series | 2 doses, 4–6 wks apart | Foals begin at 4–6 months; repeat 2-dose series |
| Annual booster | Every 12 months | Included in EWT / EWTE combination vaccines |
| Wound booster | Immediately if >6 months since last dose | Unknown status: antitoxin + toxoid at separate sites simultaneously |
| Pre-foaling booster (mares) | 4–6 weeks before foaling | Transfers colostral immunity to foal |
How C. tetani Kills
Clostridium tetani is an anaerobic bacterium that produces spores capable of surviving in soil for decades. When spores enter a wound with poor oxygen levels (deep punctures, wounds with devitalized tissue, nail punctures -- the classic tetanus-prone wound), they germinate and produce tetanospasmin, one of the most potent biological toxins known. Tetanospasmin travels up peripheral nerves to the spinal cord and brainstem, where it blocks inhibitory neurotransmitters (GABA and glycine) that normally prevent muscles from contracting continuously. Without inhibition, motor neurons fire uncontrolled, producing the characteristic rigid muscle spasms.
Horses are among the most susceptible domestic animals to tetanus -- roughly 10 times more susceptible than cattle, according to most estimates. The incubation period from wound exposure to clinical signs ranges from 1 to 3 weeks but can extend to several months if spore germination is delayed.
Clinical Signs: What Tetanus Looks Like in Horses
Early signs (days 1-3 of clinical illness): stiff gait, mild muscle stiffness, reluctance to open the mouth (trismus, or "lockjaw"), elevated tail head, and prolapse of the third eyelid across the eye when the head is raised or the horse is startled. These early signs are subtle and sometimes missed.
Progressive signs (days 3-7): severe generalized muscle rigidity producing the classic "sawhorse" stance -- legs extended stiffly outward, neck extended, back rigid; complete inability to open the mouth; difficulty swallowing leading to drooling and inability to eat or drink; nostril flaring from respiratory muscle involvement; profuse sweating.
Advanced/terminal signs: recumbency (the horse cannot stand), opisthotonus (violent backward arching of the head and neck during spasms), respiratory failure from thoracic muscle rigidity, aspiration pneumonia from inability to swallow, and death. Stimulation -- noise, touch, sudden light -- triggers violent muscle spasms and can cause fractures or myopathy in severely affected horses.
Treatment: Intensive but Often Insufficient
Treatment of tetanus in horses requires hospitalization and includes: tetanus antitoxin (to neutralize unbound toxin; does not affect toxin already bound to nerves -- this is why early treatment matters); penicillin (10,000-20,000 IU/kg IV or IM twice daily for 7-10 days) to eliminate any remaining C. tetani in the wound; wound debridement and oxygen exposure to kill anaerobic bacteria; muscle relaxants (acepromazine, methocarbamol, diazepam) to reduce spasm severity; IV fluids and nasogastric nutrition since affected horses cannot eat or drink; a dark, quiet environment to minimize stimulation-triggered spasms; and deep bedding and sling support for recumbent horses.
Even with all this, the mortality rate is 50-80%. Horses that survive the acute phase may take weeks to months to fully recover as toxin clears the nervous system. Total treatment cost routinely reaches $10,000-$30,000 for critical cases.
The Vaccine: Simple, Cheap, Life-Saving
Tetanus toxoid is included in virtually every standard equine vaccination protocol -- typically as part of a 3-way, 4-way, or 5-way combination vaccine (EWT, EWTE, or similar). The primary series is two doses 4-6 weeks apart, followed by annual boosters. Mares in late pregnancy receive a booster at 4-6 weeks pre-foaling to transfer protection to foals via colostrum. Foals vaccinated earlier than 5-6 months of age may not mount adequate responses due to maternal antibody interference; the primary series typically begins at 4-6 months with 2 doses, then annual.
Any horse sustaining a wound of unknown or suspicious nature should receive a tetanus toxoid booster immediately if not current (within 6 months) on vaccination. If the horse is unvaccinated or vaccination status is unknown, tetanus antitoxin (immediate passive protection) plus toxoid (beginning active immunization) should be given simultaneously at different injection sites.
The cost of a tetanus toxoid booster: approximately $15-30 at a routine wellness visit. The cost of treating tetanus: $10,000-$30,000, with most horses dying anyway. This is one of the clearest cost-benefit cases in all of equine preventive medicine.
Sources: AAEP Vaccination Guidelines (2020); Merck Veterinary Manual equine tetanus chapter; Green & Green (1990) tetanus in horses, Compendium of Continuing Education for the Practicing Veterinarian; USDA APHIS equine disease surveillance data.